Biotherapeutics

The US Food and Drug Administration, or FDA, has assigned Priority Review to GTC Biotherapeutics, Inc.'s Biologic License Application, or BLA, for ATryn.  

RESEARCH TRIANGLE PARK The pending $3.1 billion purchase of Talecris Biotherapeutics is not a done deal, and there's a small but real chance that the deal won't go through.  

Haemacure Corporation , a Montreal-based specialty bio-therapeutics company developing high-value human plasma-derived protein products for commercialization, provides an activity update and reports third ...